Publications by authors named "Mary Roederer"

Claim this Profile
P
Pharmacogenomics competencies in pharmacy practice: A blueprint for change.
Mary W Roederer, Grace M Kuo, David F Kisor, Reginald F Frye, James M Hoffman

J Am Pharm Assoc (2003)· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of a pharmacogenomics service in a community pharmacy.
Stefanie P Ferreri, Angelo J Greco, Natasha M Michaels, Shanna K O'Connor, Rebecca W Chater, Mary W Roederer

J Am Pharm Assoc (2003)· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fast and frugal trees: translating population-based pharmacogenomics to medication prioritization.
Tibor van Rooij, Mary Roederer, Todd Wareham, Iris van Rooij, Howard L McLeod

Per Med· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphism of ORM1 is associated with the pharmacokinetics of telmisartan.
Wang-Qing Chen, Yan Shu, Qing Li, Lin-Yong Xu, Mary W Roederer

PLoS One· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evaluation of pharmacogenomic information provided by five common drug information resources.
K T L Vaughan, Kelly L Scolaro, Heidi N Anksorus, Mary W Roederer

J Med Libr Assoc· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Making pharmacogenetic testing a reality in a community pharmacy.
Shanna K O'Connor, Stefanie P Ferreri, Natasha M Michaels, Rebecca W Chater, Anthony J Viera, Mary Roederer

J Am Pharm Assoc (2003)· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An integrated approach to research and manuscript development.
Mary Roederer, Macary Weck Marciniak, Shanna K O'Connor, Stephen F Eckel

Am J Health Syst Pharm· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does pharmacogenomics account for variability in control of acute chemotherapy-induced nausea and vomiting with 5-hydroxytryptamine type 3 receptor antagonists?
Morgan Trammel, Mary Roederer, Jai Patel, Howard McLeod

Curr Oncol Rep· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genes and beans: pharmacogenomics of renal transplant.
Brian Murray, Emily Hawes, Ruth-Ann Lee, Robert Watson, Mary W Roederer

Pharmacogenomics· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NAVAGATE: a rubric to move from pharmacogenomics science to pharmacogenomics practice.
Mary W Roederer

Pharmacogenomics· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploratory planning and implementation of a pilot pharmacogenetic program in a community pharmacy.
Shanna K O'Connor, Stefanie P Ferreri, Natasha M Michaels, Angelo J Greco, Anthony J Viera, Mary W Roederer

Pharmacogenomics· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knowledge, attitudes and education of pharmacists regarding pharmacogenetic testing.
Mary W Roederer, Marcia Van Riper, John Valgus, George Knafl, Howard McLeod

Per Med· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetics of drugs withdrawn from the market.
Wei Zhang, Mary W Roederer, Wang-Qing Chen, Lan Fan, Hong-Hao Zhou

Pharmacogenomics· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can pharmacogenomics improve malaria drug policy?
Mary W Roederer, Howard McLeod, Jonathan J Juliano

Bull World Health Organ· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomics in a community pharmacy: ACT now.
Lisa Padgett, Shanna O'Connor, Mary Roederer, Howard McLeod, Stefanie Ferreri

J Am Pharm Assoc (2003)· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetics and rational drug use around the world.
Mary W Roederer, Francisco Sanchez-Giron, Kusha Kalideen, William Kudzi, Howard L McLeod

Pharmacogenomics· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global formulary review: how do we integrate pharmacogenomic information?
Lindsey B Poppe, Mary W Roederer

Ann Pharmacother· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applying the genome to national drug formulary policy in the developing world.
Mary W Roederer, Howard L McLeod

Pharmacogenomics· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Institutional profile. UNC Institute for Pharmacogenomics and Individualized Therapy: interdisciplinary research for individual care.
Tejinder K Rakhra-Burris, J Todd Auman, Patricia Deverka, Lynn G Dressler, James P Evans, Mary W Roederer

Pharmacogenomics· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytochrome P450 enzymes and genotype-guided drug therapy.
Mary W Roederer

Curr Opin Mol Ther· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacists and pharmacogenetics.
Mary W Roederer

Am J Health Syst Pharm· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nevirapine hypersensitivity reaction: will the real HLA please stand up?
Janelle M Hoskins, Mary W Roederer, Howard L McLeod

Curr Opin Mol Ther· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accounting for the sedative and analgesic effects of medication changes during patient participation in clinical research studies: measurement development and application to a sample of institutionalized geriatric patients.
Philip Sloane, Jena Ivey, Mary Roth, Mary Roederer, Christianna S Williams

Contemp Clin Trials· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FPIN's Clinical inquiries. Risks and benefits of combination contraceptives.
Mary W Roederer, Jean C Blackwell

Am Fam Physician· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical inquiries. What are the relative risks and benefits of progestin-only contraceptives?
Mary W Roederer, Jean C Blackwell, Paul Crawford

J Fam Pract· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis